B. Buerk

Decision Regret and Quality of Life after Focal Therapy with Vascular-Targeted Photodynamic Therapy (TOOKAD®) for Localized Prostate Cancer

A. Borkowetz, S. Propping, A. Zacharis, 2021, Urologia Internationalis.

First-line immune combination therapies for non-clear cell vs. clear cell metastatic renal cell carcinoma: Real-world multicenter data from Germany

C. Kalogirou, S. Banek, B. Hoeh, 2024, Clinical Genitourinary Cancer.

Early CRP kinetics to predict long‐term efficacy of first‐line immune‐checkpoint inhibition combination therapies in metastatic renal cell carcinoma: an updated multicentre real‐world experience applying different CRP kinetics definitions

C. Kalogirou, N. Klümper, A. Mattigk, 2023, Clinical & translational immunology.